Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 950 of 3173 entries
View as:

A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT01441388 Org: User:
Start: 12/31/11 End: 11/30/13 Due: 11/30/14

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00002139 Org: User:
Start: - End: - Due: -

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03950232 Org: User:
Start: 09/05/19 End: 06/19/29 Due: 06/19/30

Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT04549480 Org: User:
Start: 09/16/20 End: 01/15/21 Due: 01/15/22

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Phase: N/A Priority: Normal
NCT ID: NCT01644643 Org: User:
Start: 01/31/13 End: 09/30/14 Due: 09/30/15

Muscle Malonyl Coa Biomarker Assay Development

Phase: N/A Priority: Normal
NCT ID: NCT01003444 Org: User:
Start: 11/30/09 End: 11/30/09 Due: 11/30/10

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00925002 Org: User:
Start: 08/05/09 End: 07/08/20 Due: 07/08/21

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Phase: N/A Priority: Normal
NCT ID: NCT00163189 Org: User:
Start: 01/31/05 End: 12/31/14 Due: 12/31/15

A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02539550 Org: User:
Start: 08/31/15 End: 05/31/16 Due: 05/31/17

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

Phase: N/A Priority: Normal
NCT ID: NCT06531538 Org: User:
Start: 07/30/24 End: 09/19/25 Due: 09/19/26

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

Phase: N/A Priority: Normal
NCT ID: NCT06163326 Org: User:
Start: 01/19/24 End: 01/30/27 Due: 01/30/28

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Phase: N/A Priority: Normal
NCT ID: NCT06564389 Org: User:
Start: 11/05/24 End: 06/02/27 Due: 06/02/28

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00428597 Org: User:
Start: 06/30/07 End: 04/30/09 Due: 04/30/10

A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01119235 Org: User:
Start: 05/31/10 End: 07/31/10 Due: 07/31/11

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Phase: N/A Priority: Normal
NCT ID: NCT05518123 Org: User:
Start: 11/07/22 End: 07/09/25 Due: 07/09/26

A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

Phase: N/A Priority: Normal
NCT ID: NCT00254566 Org: User:
Start: 02/28/06 End: 08/31/08 Due: 08/31/09

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT00364182 Org: User:
Start: 05/31/07 End: 10/31/10 Due: 10/31/11

A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01169714 Org: User:
Start: 08/31/10 End: 12/31/10 Due: 12/31/11

Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00553696 Org: User:
Start: 11/30/07 End: 03/31/14 Due: 03/31/15

PF-04634817 Renal Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT01791855 Org: User:
Start: 05/10/13 End: 09/03/13 Due: 09/03/14

A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)

Phase: N/A Priority: Normal
NCT ID: NCT02407353 Org: User:
Start: 10/31/15 End: 03/31/16 Due: 03/31/17

This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.

Phase: N/A Priority: Normal
NCT ID: NCT00380939 Org: User:
Start: 04/30/99 End: 12/31/00 Due: 12/31/01

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation

Phase: N/A Priority: Normal
NCT ID: NCT01438957 Org: User:
Start: 06/03/11 End: 11/18/11 Due: 11/18/12

Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01753791 Org: User:
Start: 11/30/12 End: 06/30/13 Due: 06/30/14

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04517669 Org: User:
Start: 05/17/21 End: 07/30/24 Due: 07/30/25